NASDAQ:LQDA Liquidia (LQDA) Stock Price, News & Analysis $9.95 -0.32 (-3.12%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Liquidia alerts: Email Address About Liquidia Stock (NASDAQ:LQDA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Liquidia alerts:Sign Up Key Stats Today's Range$9.92▼$10.2550-Day Range$8.90▼$14.1152-Week Range$5.71▼$16.99Volume1.53 million shsAverage Volume1.01 million shsMarket Capitalization$760.32 millionP/E RatioN/ADividend YieldN/APrice Target$23.14Consensus RatingModerate Buy Company OverviewLiquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.Read More… Trump’s weapon lurks in abandoned America (Ad)Unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…Go here now to watch my new documentary Liquidia Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 74th PercentileLiquidia scored higher than 74% of companies evaluated by MarketBeat, and ranked 287th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingLiquidia has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageLiquidia has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Liquidia's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Liquidia are expected to grow in the coming year, from ($1.69) to ($1.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -6.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -6.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLiquidia has a P/B Ratio of 13.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Liquidia's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.04% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 10.2, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently decreased by 1.84%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.04% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 10.2, which indicates bearish sentiment.Change versus previous monthShort interest in Liquidia has recently decreased by 1.84%, indicating that investor sentiment is improving. News and Social Media1.7 / 5News Sentiment0.04 News SentimentLiquidia has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Liquidia this week, compared to 4 articles on an average week.Search InterestOnly 6 people have searched for LQDA on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership5.0 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have bought 455.06% more of their company's stock than they have sold. Specifically, they have bought $1,426,500.00 in company stock and sold $256,998.00 in company stock.Percentage Held by Insiders31.60% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.54% of the stock of Liquidia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Liquidia's insider trading history. Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Stock News HeadlinesLiquidia Co. (NASDAQ:LQDA) CFO Michael Kaseta Sells 1,079 SharesSeptember 5, 2024 | insidertrades.comLiquidia (NASDAQ:LQDA) Shares Gap Up to $10.00September 19 at 6:51 AM | americanbankingnews.comTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…September 20, 2024 | Porter & Company (Ad)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDASeptember 17 at 6:35 PM | prnewswire.comWith 38% ownership in Liquidia Corporation (NASDAQ:LQDA), institutional investors have a lot riding on the businessSeptember 17 at 12:39 AM | finance.yahoo.comLiquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137MSeptember 17 at 12:39 AM | marketwatch.comStatistics Canada says manufacturing sales up 1.4% in July at $71BSeptember 17 at 12:39 AM | ca.finance.yahoo.comCourt Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionSeptember 17 at 12:39 AM | markets.businessinsider.comSee More Headlines LQDA Stock Analysis - Frequently Asked Questions How have LQDA shares performed this year? Liquidia's stock was trading at $12.03 at the beginning of 2024. Since then, LQDA stock has decreased by 16.8% and is now trading at $10.01. View the best growth stocks for 2024 here. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) issued its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.02. The company earned $3.66 million during the quarter, compared to analyst estimates of $7.92 million. Liquidia had a negative net margin of 755.46% and a negative trailing twelve-month return on equity of 183.57%. When did Liquidia IPO? Liquidia (LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. Who are Liquidia's major shareholders? Top institutional shareholders of Liquidia include Susquehanna International Group LLP, Bank of New York Mellon Corp (0.27%), HighVista Strategies LLC (0.16%) and Squarepoint Ops LLC (0.11%). Insiders that own company stock include Caligan Partners Lp, Russell Schundler, Michael Kaseta, Rajeev Saggar, Robert A Lippe, Scott Moomaw, Jason Adair and Arthur S Kirsch. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some other companies that Liquidia investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA) and Inovio Pharmaceuticals (INO). Company Calendar Last Earnings8/07/2024Today9/20/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryMedical Equipment Current SymbolNASDAQ:LQDA CUSIPN/A CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees50Year FoundedN/APrice Target and Rating Average Stock Price Target$23.14 High Stock Price Target$30.00 Low Stock Price Target$3.00 Potential Upside/Downside+130.0%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($1.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-78,500,000.00 Net Margins-755.46% Pretax Margin-755.46% Return on Equity-183.57% Return on Assets-74.19% Debt Debt-to-Equity RatioN/A Current Ratio6.08 Quick Ratio5.78 Sales & Book Value Annual Sales$14.84 million Price / Sales51.80 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book13.78Miscellaneous Outstanding Shares76,414,000Free Float52,267,000Market Cap$768.72 million OptionableOptionable Beta0.22 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (NASDAQ:LQDA) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.